R&D, Support Services for Scientific and Technical Consulting Services
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40122D00002
NAICS
541690 - Other Scientific and Technical Consulting Services
Classification Code
-
Additional Details
Documents1
The Food and Drug Administration (FDA) Office of Acquisition and Grant Services has issued an award notice for the provision of research and development (R&D) support services, specifically focused on scientific and technical consulting. This procurement, identified by number 75F40122D00002, is classified under NAICS code 541690, which encompasses "Other Scientific and Technical Consulting Services" as defined in the 2022 NAICS version.
The primary objective of this contract is to secure expert consulting services that will bolster the FDA’s scientific and technical initiatives. The scope of work is expected to include a range of R&D support activities, with an emphasis on providing specialized knowledge and guidance to advance the FDA’s mission. Contractors engaged under this award will likely be tasked with delivering high-level scientific and technical advice, supporting research projects, and contributing to the development and implementation of innovative solutions within the agency’s operational framework.
The place of performance for this contract is Washington, District of Columbia, indicating that services will be rendered within the nation’s capital, potentially at FDA headquarters or affiliated facilities. This central location underscores the importance and visibility of the work, as it directly supports federal regulatory and scientific functions.
The contracting entity for this opportunity is the FDA Office of Acquisition and Grant Services, a federal office responsible for managing procurement activities that support the agency’s diverse programs. Interested parties or current awardees may direct inquiries to the primary contact, Erika Eam, who can be reached via email at [email protected].
This award notice is currently active and was posted on January 27, 2022. The opportunity is listed on SAM.gov, with further details and attachments accessible through the provided link: https://sam.gov/opp/83db984a6e0043f294496b7e763b726d/view.
Key elements that remain constant throughout the contract lifecycle include the focus on scientific and technical consulting within the R&D domain, the federal nature of the contracting entity, and the location of performance in Washington, DC. The procurement is not specified as a set-aside for any particular business category, and no special considerations or additional documentation requirements are noted in the available information.
Contractors evaluating this opportunity should possess robust capabilities in scientific and technical consulting, with a proven track record of supporting federal R&D initiatives. The engagement offers the potential to contribute meaningfully to the FDA’s mission, providing expert guidance and innovative solutions in a dynamic regulatory environment.